注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Forbion European Acquisition Corp是一家空白支票公司。该公司为与一项或多项业务进行合并、股本交换、资产收购、股票购买、重组或类似业务合并而成立。该公司未选择任何具体的业务合并目标,也没有任何人代表其与任何业务合并目标直接或间接发起任何实质性讨论。该公司打算将其搜索重点放在生活方式、技术、医疗保健和健康领域。该公司尚未开展任何业务,也未产生任何收入。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Paul D. Robbins | - | - | Chairman of Scientific Advisory Board |
John C. Brown | - | 1999 | Co-Founder and Member of Scientific Advisory Board |
Jason D. Hanson | 54 | 2018 | CEO & Director |
Scott Eric Plevy | - | 2012 | Member of Clinical Advisory Board |
A. Sinclair Dunlop | 51 | 2008 | Observer |
Russell J. Mumper | - | 2010 | Member of Scientific Advisory Board |
Jay K. Kolls | - | - | Member of Scientific Advisory Board |
Imre Kovesdi | 76 | - | Member of Advisory Board |
Marshall A. Dhal | - | - | Member of Scientific Advisory Board |
Christopher J. Rhodes | - | 2006 | Member of Scientific Advisory Board |
Raymond V. Rajotte | - | - | Member of Scientific Advisory Board |
Kevan Jacobson | - | - | Member of Scientific Advisory Board |
Lota S. Zoth | 63 | 2023 | Independent Director |
Brian Gordon Feagan | - | 2012 | Member of Clinical Advisory Board |
Richard N. Fedorak | - | - | Member of Clinical Advisory Board |
Richard M. Glickman | 66 | 2023 | Independent Non-Executive Director |
Geert D’Haens | - | 2012 | Member of Clinical Advisory Board |
Jasper M. Bos | 49 | 2023 | Director |
Gerald A. Brunk | 55 | 2023 | Independent Director |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核